Human Normal Immunoglobulin Market
1 Study Coverage
1.1 Human Normal Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Human Normal Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Normal Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Normal Immunoglobulin Sales Estimates and Forecasts 2017-2028
2.2 Global Human Normal Immunoglobulin Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Normal Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Normal Immunoglobulin Sales by Region
2.4.1 Global Human Normal Immunoglobulin Sales by Region (2017-2022)
2.4.2 Global Sales Human Normal Immunoglobulin by Region (2023-2028)
2.5 Global Human Normal Immunoglobulin Revenue by Region
2.5.1 Global Human Normal Immunoglobulin Revenue by Region (2017-2022)
2.5.2 Global Human Normal Immunoglobulin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Normal Immunoglobulin Sales by Manufacturers
3.1.1 Global Top Human Normal Immunoglobulin Manufacturers by Sales (2017-2022)
3.1.2 Global Human Normal Immunoglobulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Normal Immunoglobulin in 2021
3.2 Global Human Normal Immunoglobulin Revenue by Manufacturers
3.2.1 Global Human Normal Immunoglobulin Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Normal Immunoglobulin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Normal Immunoglobulin Revenue in 2021
3.3 Global Human Normal Immunoglobulin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Normal Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Normal Immunoglobulin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Normal Immunoglobulin Sales by Type
4.1.1 Global Human Normal Immunoglobulin Historical Sales by Type (2017-2022)
4.1.2 Global Human Normal Immunoglobulin Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
4.2 Global Human Normal Immunoglobulin Revenue by Type
4.2.1 Global Human Normal Immunoglobulin Historical Revenue by Type (2017-2022)
4.2.2 Global Human Normal Immunoglobulin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
4.3 Global Human Normal Immunoglobulin Price by Type
4.3.1 Global Human Normal Immunoglobulin Price by Type (2017-2022)
4.3.2 Global Human Normal Immunoglobulin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Normal Immunoglobulin Sales by Application
5.1.1 Global Human Normal Immunoglobulin Historical Sales by Application (2017-2022)
5.1.2 Global Human Normal Immunoglobulin Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
5.2 Global Human Normal Immunoglobulin Revenue by Application
5.2.1 Global Human Normal Immunoglobulin Historical Revenue by Application (2017-2022)
5.2.2 Global Human Normal Immunoglobulin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
5.3 Global Human Normal Immunoglobulin Price by Application
5.3.1 Global Human Normal Immunoglobulin Price by Application (2017-2022)
5.3.2 Global Human Normal Immunoglobulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Normal Immunoglobulin Market Size by Type
6.1.1 North America Human Normal Immunoglobulin Sales by Type (2017-2028)
6.1.2 North America Human Normal Immunoglobulin Revenue by Type (2017-2028)
6.2 North America Human Normal Immunoglobulin Market Size by Application
6.2.1 North America Human Normal Immunoglobulin Sales by Application (2017-2028)
6.2.2 North America Human Normal Immunoglobulin Revenue by Application (2017-2028)
6.3 North America Human Normal Immunoglobulin Market Size by Country
6.3.1 North America Human Normal Immunoglobulin Sales by Country (2017-2028)
6.3.2 North America Human Normal Immunoglobulin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Normal Immunoglobulin Market Size by Type
7.1.1 Europe Human Normal Immunoglobulin Sales by Type (2017-2028)
7.1.2 Europe Human Normal Immunoglobulin Revenue by Type (2017-2028)
7.2 Europe Human Normal Immunoglobulin Market Size by Application
7.2.1 Europe Human Normal Immunoglobulin Sales by Application (2017-2028)
7.2.2 Europe Human Normal Immunoglobulin Revenue by Application (2017-2028)
7.3 Europe Human Normal Immunoglobulin Market Size by Country
7.3.1 Europe Human Normal Immunoglobulin Sales by Country (2017-2028)
7.3.2 Europe Human Normal Immunoglobulin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Normal Immunoglobulin Market Size by Type
8.1.1 Asia Pacific Human Normal Immunoglobulin Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Normal Immunoglobulin Revenue by Type (2017-2028)
8.2 Asia Pacific Human Normal Immunoglobulin Market Size by Application
8.2.1 Asia Pacific Human Normal Immunoglobulin Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Normal Immunoglobulin Revenue by Application (2017-2028)
8.3 Asia Pacific Human Normal Immunoglobulin Market Size by Region
8.3.1 Asia Pacific Human Normal Immunoglobulin Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Normal Immunoglobulin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Normal Immunoglobulin Market Size by Type
9.1.1 Latin America Human Normal Immunoglobulin Sales by Type (2017-2028)
9.1.2 Latin America Human Normal Immunoglobulin Revenue by Type (2017-2028)
9.2 Latin America Human Normal Immunoglobulin Market Size by Application
9.2.1 Latin America Human Normal Immunoglobulin Sales by Application (2017-2028)
9.2.2 Latin America Human Normal Immunoglobulin Revenue by Application (2017-2028)
9.3 Latin America Human Normal Immunoglobulin Market Size by Country
9.3.1 Latin America Human Normal Immunoglobulin Sales by Country (2017-2028)
9.3.2 Latin America Human Normal Immunoglobulin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Normal Immunoglobulin Market Size by Type
10.1.1 Middle East and Africa Human Normal Immunoglobulin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Normal Immunoglobulin Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Normal Immunoglobulin Market Size by Application
10.2.1 Middle East and Africa Human Normal Immunoglobulin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Normal Immunoglobulin Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Normal Immunoglobulin Market Size by Country
10.3.1 Middle East and Africa Human Normal Immunoglobulin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Normal Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Behring Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Grifols Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Biotest
11.3.1 Biotest Corporation Information
11.3.2 Biotest Overview
11.3.3 Biotest Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biotest Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotest Recent Developments
11.4 Kedrion
11.4.1 Kedrion Corporation Information
11.4.2 Kedrion Overview
11.4.3 Kedrion Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kedrion Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion Recent Developments
11.5 CBPO
11.5.1 CBPO Corporation Information
11.5.2 CBPO Overview
11.5.3 CBPO Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CBPO Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CBPO Recent Developments
11.6 Emergent (Cangene)
11.6.1 Emergent (Cangene) Corporation Information
11.6.2 Emergent (Cangene) Overview
11.6.3 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent (Cangene) Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent (Cangene) Recent Developments
11.7 Kamada
11.7.1 Kamada Corporation Information
11.7.2 Kamada Overview
11.7.3 Kamada Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kamada Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kamada Recent Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Overview
11.8.3 CNBG Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CNBG Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Corporation Information
11.9.2 Hualan Bio Overview
11.9.3 Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Bio Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Bio Recent Developments
11.10 Shanghai RAAS
11.10.1 Shanghai RAAS Corporation Information
11.10.2 Shanghai RAAS Overview
11.10.3 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shanghai RAAS Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai RAAS Recent Developments
11.11 Sichuan Yuanda Shuyang
11.11.1 Sichuan Yuanda Shuyang Corporation Information
11.11.2 Sichuan Yuanda Shuyang Overview
11.11.3 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sichuan Yuanda Shuyang Recent Developments
11.12 ADMA Biologics
11.12.1 ADMA Biologics Corporation Information
11.12.2 ADMA Biologics Overview
11.12.3 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ADMA Biologics Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ADMA Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Normal Immunoglobulin Industry Chain Analysis
12.2 Human Normal Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Normal Immunoglobulin Production Mode & Process
12.4 Human Normal Immunoglobulin Sales and Marketing
12.4.1 Human Normal Immunoglobulin Sales Channels
12.4.2 Human Normal Immunoglobulin Distributors
12.5 Human Normal Immunoglobulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Normal Immunoglobulin Industry Trends
13.2 Human Normal Immunoglobulin Market Drivers
13.3 Human Normal Immunoglobulin Market Challenges
13.4 Human Normal Immunoglobulin Market Restraints
14 Key Findings in The Global Human Normal Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Normal Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hepatitis B Immunoglobulins
Table 3. Major Manufacturers of Rabies Immunoglobulins
Table 4. Major Manufacturers of Tetanus Immunoglobulins
Table 5. Major Manufacturers of Others
Table 6. Global Human Normal Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Human Normal Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Human Normal Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 9. Global Human Normal Immunoglobulin Sales Market Share by Region (2017-2022)
Table 10. Global Human Normal Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 11. Global Human Normal Immunoglobulin Sales Market Share by Region (2023-2028)
Table 12. Global Human Normal Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Human Normal Immunoglobulin Revenue Market Share by Region (2017-2022)
Table 14. Global Human Normal Immunoglobulin Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Human Normal Immunoglobulin Revenue Market Share by Region (2023-2028)
Table 16. Global Human Normal Immunoglobulin Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Human Normal Immunoglobulin Sales Share by Manufacturers (2017-2022)
Table 18. Global Human Normal Immunoglobulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Human Normal Immunoglobulin Revenue Share by Manufacturers (2017-2022)
Table 20. Human Normal Immunoglobulin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Human Normal Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Normal Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Normal Immunoglobulin as of 2021)
Table 23. Human Normal Immunoglobulin Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Human Normal Immunoglobulin Product Offered
Table 25. Date of Manufacturers Enter into Human Normal Immunoglobulin Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Normal Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 28. Global Human Normal Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 29. Global Human Normal Immunoglobulin Sales Share by Type (2017-2022)
Table 30. Global Human Normal Immunoglobulin Sales Share by Type (2023-2028)
Table 31. Global Human Normal Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Human Normal Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Human Normal Immunoglobulin Revenue Share by Type (2017-2022)
Table 34. Global Human Normal Immunoglobulin Revenue Share by Type (2023-2028)
Table 35. Human Normal Immunoglobulin Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Human Normal Immunoglobulin Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Human Normal Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 38. Global Human Normal Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 39. Global Human Normal Immunoglobulin Sales Share by Application (2017-2022)
Table 40. Global Human Normal Immunoglobulin Sales Share by Application (2023-2028)
Table 41. Global Human Normal Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Human Normal Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Human Normal Immunoglobulin Revenue Share by Application (2017-2022)
Table 44. Global Human Normal Immunoglobulin Revenue Share by Application (2023-2028)
Table 45. Human Normal Immunoglobulin Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Human Normal Immunoglobulin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Human Normal Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 48. North America Human Normal Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 49. North America Human Normal Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Human Normal Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Human Normal Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 52. North America Human Normal Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 53. North America Human Normal Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Human Normal Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Human Normal Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 56. North America Human Normal Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 57. North America Human Normal Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Human Normal Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Human Normal Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 60. Europe Human Normal Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 61. Europe Human Normal Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Human Normal Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Human Normal Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 64. Europe Human Normal Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 65. Europe Human Normal Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Human Normal Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Human Normal Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 68. Europe Human Normal Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 69. Europe Human Normal Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Human Normal Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Human Normal Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Human Normal Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Human Normal Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Human Normal Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Human Normal Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Human Normal Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Human Normal Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Human Normal Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Human Normal Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Human Normal Immunoglobulin Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Human Normal Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Human Normal Immunoglobulin Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Human Normal Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Human Normal Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Human Normal Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Human Normal Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Human Normal Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Human Normal Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Human Normal Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Human Normal Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Human Normal Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Human Normal Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Human Normal Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Human Normal Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Human Normal Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Human Normal Immunoglobulin Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Human Normal Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Human Normal Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Human Normal Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Human Normal Immunoglobulin Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Human Normal Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Human Normal Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Human Normal Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Human Normal Immunoglobulin Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Human Normal Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Human Normal Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 107. CSL Behring Corporation Information
Table 108. CSL Behring Description and Major Businesses
Table 109. CSL Behring Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. CSL Behring Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Behring Recent Developments
Table 112. Grifols Corporation Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Grifols Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. Biotest Corporation Information
Table 118. Biotest Description and Major Businesses
Table 119. Biotest Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Biotest Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biotest Recent Developments
Table 122. Kedrion Corporation Information
Table 123. Kedrion Description and Major Businesses
Table 124. Kedrion Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Kedrion Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Kedrion Recent Developments
Table 127. CBPO Corporation Information
Table 128. CBPO Description and Major Businesses
Table 129. CBPO Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. CBPO Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. CBPO Recent Developments
Table 132. Emergent (Cangene) Corporation Information
Table 133. Emergent (Cangene) Description and Major Businesses
Table 134. Emergent (Cangene) Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Emergent (Cangene) Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Emergent (Cangene) Recent Developments
Table 137. Kamada Corporation Information
Table 138. Kamada Description and Major Businesses
Table 139. Kamada Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Kamada Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Kamada Recent Developments
Table 142. CNBG Corporation Information
Table 143. CNBG Description and Major Businesses
Table 144. CNBG Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. CNBG Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CNBG Recent Developments
Table 147. Hualan Bio Corporation Information
Table 148. Hualan Bio Description and Major Businesses
Table 149. Hualan Bio Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Hualan Bio Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hualan Bio Recent Developments
Table 152. Shanghai RAAS Corporation Information
Table 153. Shanghai RAAS Description and Major Businesses
Table 154. Shanghai RAAS Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Shanghai RAAS Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shanghai RAAS Recent Developments
Table 157. Sichuan Yuanda Shuyang Corporation Information
Table 158. Sichuan Yuanda Shuyang Description and Major Businesses
Table 159. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Sichuan Yuanda Shuyang Recent Developments
Table 162. ADMA Biologics Corporation Information
Table 163. ADMA Biologics Description and Major Businesses
Table 164. ADMA Biologics Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. ADMA Biologics Human Normal Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. ADMA Biologics Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Human Normal Immunoglobulin Distributors List
Table 170. Human Normal Immunoglobulin Customers List
Table 171. Human Normal Immunoglobulin Market Trends
Table 172. Human Normal Immunoglobulin Market Drivers
Table 173. Human Normal Immunoglobulin Market Challenges
Table 174. Human Normal Immunoglobulin Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Normal Immunoglobulin Product Picture
Figure 3. Global Human Normal Immunoglobulin Market Share by Type in 2021 & 2028
Figure 3. Hepatitis B Immunoglobulins Product Picture
Figure 4. Rabies Immunoglobulins Product Picture
Figure 5. Tetanus Immunoglobulins Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Normal Immunoglobulin Market Share by Application in 2021 & 2028
Figure 8. Government Institutions
Figure 9. Private Sector
Figure 10. Other
Figure 11. Human Normal Immunoglobulin Report Years Considered
Figure 12. Global Human Normal Immunoglobulin Sales 2017-2028 (K Units)
Figure 13. Global Human Normal Immunoglobulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Human Normal Immunoglobulin Revenue 2017-2028 (US$ Million)
Figure 15. Global Human Normal Immunoglobulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Human Normal Immunoglobulin Sales Market Share by Region (2017-2022)
Figure 17. Global Human Normal Immunoglobulin Sales Market Share by Region (2023-2028)
Figure 18. North America Human Normal Immunoglobulin Sales YoY (2017-2028) & (K Units)
Figure 19. North America Human Normal Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Human Normal Immunoglobulin Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Human Normal Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Human Normal Immunoglobulin Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Human Normal Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Human Normal Immunoglobulin Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Human Normal Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Human Normal Immunoglobulin Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Human Normal Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Human Normal Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Human Normal Immunoglobulin in the World: Market Share by Human Normal Immunoglobulin Revenue in 2021
Figure 30. Global Human Normal Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 32. Global Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 33. Global Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 34. Global Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 35. North America Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 36. North America Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 37. North America Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 38. North America Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 39. North America Human Normal Immunoglobulin Sales Share by Country (2017-2028)
Figure 40. North America Human Normal Immunoglobulin Revenue Share by Country (2017-2028)
Figure 41. U.S. Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 44. Europe Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 45. Europe Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 46. Europe Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 47. Europe Human Normal Immunoglobulin Sales Share by Country (2017-2028)
Figure 48. Europe Human Normal Immunoglobulin Revenue Share by Country (2017-2028)
Figure 49. Germany Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 50. France Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Human Normal Immunoglobulin Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Human Normal Immunoglobulin Revenue Share by Region (2017-2028)
Figure 60. China Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 63. India Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 71. Latin America Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 73. Latin America Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Human Normal Immunoglobulin Sales Share by Country (2017-2028)
Figure 75. Latin America Human Normal Immunoglobulin Revenue Share by Country (2017-2028)
Figure 76. Mexico Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Human Normal Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Human Normal Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Human Normal Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Normal Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Human Normal Immunoglobulin Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Human Normal Immunoglobulin Revenue Share by Country (2017-2028)
Figure 85. Turkey Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Human Normal Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 88. Human Normal Immunoglobulin Value Chain
Figure 89. Human Normal Immunoglobulin Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
